Tilmetamine is a dissociative drug of the arylcyclohexylamine family related to tiletamine. It is the analogue of tiletamine in which the N-ethyl group has been replaced with an N-methyl group. The drug is said to be 3 to 5 times more potent than ketamine and to have a longer duration. It is reported to produce adverse effects, such as blurred vision. Hamilton Morris and Nervewing have described tilmetamine as producing long-lasting toxicity. Tilmetamine is expected to act as an NMDA receptor antagonist similarly to tiletamine and ketamine. It was encountered as a novel designer drug online in August 2024.
See also Tiletamine Arylcyclohexylamine
References
External links Tilmetamine - Reddit Search - Reddit Tilemetamine - Bluelight


